NSE filing, NSE: SUZLON. Summary written from the filing by ALFA Finder's alert engine.
Suzlon Energy Ltd: key numbers
- Share price
- ₹37.30
- Market cap
- ₹51,275 Cr
- Revenue (annual)
- ₹16,732 Cr
- Net profit (annual)
- ₹3,163 Cr
- P/E (TTM)
- 16.3×Sector 52.2×
- Promoter holding
- 11.70%-0.01% QoQ
- FII holding
- 23.63%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Suzlon Energy Ltd
All →Suzlon Energy Credit Rating
Suzlon Energy's CRISIL long-term rating was upgraded to AA- (Stable) from A+. Short-term rating also upgraded to A1+ for Rs.5685 Crore bank loan facilities.
Suzlon Energy Employee Stock Options
Suzlon Energy has allotted 3,46,000 equity shares to employees under its ESOP 2022 scheme. The exercise of these options has realized ₹0.9965 Crore.
- Value
- ₹1.00 Cr
Suzlon Energy Price Movement Clarification
Suzlon Energy Limited has clarified to the exchanges regarding the recent material price movement in its stock, stating that no undisclosed event triggered the change.
Suzlon Energy Employee Stock Options
Suzlon Energy allotted 6,40,726 equity shares under its ESOP 2022 scheme. This exercise of stock options increases the company's paid-up capital.
Suzlon Energy Annual General Meeting
Suzlon Energy Ltd held its 31st Annual General Meeting on September 11, 2026. The company disclosed the meeting proceedings and voting results for its agenda items.
Suzlon Energy Bags New Order from Ayana Renewable Power Limited
Suzlon secured a 200 MW wind energy EPC order from Ayana Renewable Power for Limbawas, Madhya Pradesh. Sixty-four S144 turbines will be installed through comprehensive project execution.
- From
- Ayana Renewable Power Limited
- wind turbine capacity
- 200 MW
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.